Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Long-term Safety and Efficacy of Belzutifan in Von Hippel-Lindau Syndrome: A VHL Coordinating Care Center Experience.
Journal: Journal of kidney cancer and VHL
Published: June 15, 2025
The safety profile of belzutifan in renal tumors: real-world data from a tertiary academic center.
Journal: The oncologist
Published: May 29, 2025
Limited availability of variant-specific germ line data creates challenges in the interpretation of myeloid NGS panels.
Journal: Blood vessels, thrombosis & hemostasis
Published: January 03, 2025
Showing 1-3 of 3
Last Updated: 09/26/2026